4//SEC Filing
Tan Aik Na 4
Accession 0000950170-25-108290
CIK 0001631574other
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 8:00 PM ET
Size
7.4 KB
Accession
0000950170-25-108290
Insider Transaction Report
Form 4
Tan Aik Na
Director
Transactions
- Award
Ordinary Shares
2025-08-11+25,400→ 40,388 total - Award
Share Option (right to buy)
2025-08-11+152,400→ 152,400 totalExercise: $8.11Exp: 2030-08-11→ Ordinary Shares (152,400 underlying)
Footnotes (2)
- [F1]The reporting person was granted this restricted share unit award (RSU) pursuant to the 2025 Non-Employee Director Compensation Policy. The RSU vests as to 50% on each of (i) the earlier of the Company's 2026 annual general meeting or August 11, 2026; and (ii) the earlier of the Company's 2027 annual general meeting or August 11, 2027.
- [F2]The reporting person was granted this option pursuant to the 2025 Non-Employee Director Compensation Policy. The option vests as to 12.5% on a quarterly basis beginning August 11, 2025, through the two-year period following the grant date.
Documents
Issuer
Wave Life Sciences Ltd.
CIK 0001631574
Entity typeother
Related Parties
1- filerCIK 0001821285
Filing Metadata
- Form type
- 4
- Filed
- Aug 12, 8:00 PM ET
- Accepted
- Aug 13, 8:00 PM ET
- Size
- 7.4 KB